Stock report · Delisted · Nasdaq
IGM Biosciences Inc (IGMS)
1.30USD Delisted Final close · Aug 12, 2025
IGMS no longer trades. IGM Biosciences was delisted from the Nasdaq in August 2025.
All prices on this page are historical. The last trade was on August 12, 2025, at $1.30.
IGMS stock price history
Final trading statistics
- Final close
- $1.30
- Final trading day
- Aug 12, 2025
- Market cap at delisting
- $47.57M
- Shares outstanding
- 36.59M
- Final 52-week range
- $0.92 – $22.50
- Avg. volume (final 3 mo.)
- 614,088
- All-time high
- $121.23 · Feb 2021
- All-time low
- $1.02 · Apr 2025
- Return since IPO
- -94.7%
- Beta
- 0.59
- Book value / share
- $1.68
- Price / book
- 0.78
About IGM Biosciences Inc
IGM Biosciences, Inc. was a biotechnology company developing Immunoglobulin M antibodies to treat cancer and autoimmune and inflammatory diseases. Known as Palingen, Inc. until 2010, it was incorporated in 1993 and based in Mountain View, California. It became a subsidiary of Concentra Biosciences, LLC as of August 14, 2025, and its stock was delisted from the Nasdaq that month, with the last trade on August 12, 2025 at $1.30.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Mountain View, CA
- Employees
- 16
- IPO date
- September 18, 2019
- Delisted
- August 12, 2025
- SEC CIK
- 1496323
IGM Biosciences financials before the delisting
The last 5 fiscal years IGM Biosciences reported as a public company, fiscal year ending December.
IGMS revenue and net income
IGMS earnings per share
IGMS annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $2.68M | −$195.8M | −$3.24 |
| FY2023 | $2.13M | −$246.4M | −$4.81 |
| FY2022 | $1.07M | −$214.2M | −$5.37 |
| FY2021 | $366.0K | −$160.7M | −$4.93 |
| FY2020 | $0.00 | −$80.3M | −$2.65 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
IGM Biosciences stock FAQ
What happened to IGM Biosciences stock?
IGM Biosciences was delisted from the Nasdaq in August 2025. The final close was $1.30 on August 12, 2025.
Can I still buy IGMS stock?
No. IGMS is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on August 12, 2025.
What was the last price of IGMS?
IGMS last closed at $1.30 on August 12, 2025, which valued the company at about $47.57M.
How did IGM Biosciences do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, IGM Biosciences reported revenue of $2.68M and net income of −$195.8M.
When did IGM Biosciences go public?
IGM Biosciences shares started trading on September 18, 2019.
IGMS no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.